Cerebrospinal fluid (CSF) analysis has perhaps the strongest diagnostic and prognostic potential for Alzheimer disease to date, yet some think the field is not harnessing its full power because ...

Plerixafor (Mozobil, Sanofi, Cambridge, MA, USA) is a small molecule that reversibly disrupts the interaction of CXCR4 with its ligand SDF-1, allowing the release of SCs from the marrow. 12 It is ...

The persuasive Global G-CSF/PEG-G-CSF Market report suggests that the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has ...

FRISCO, Texas, April 10, 2025 /CNW/ -- HITRUST, the leader in information security assurance, today announced the release of its latest Cyber Threat Adaptive Quarterly Update (Q4 2024) — confirming ...